๐Ÿ“–
Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial.
Adekunle RO, Wu Q, Sattar A, Ansari-Gilani K, Labbato D, Fletcher AA, McComsey AD, Eckard AR

Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Open Forum Infect Dis.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial.
Author / Organization Adekunle RO, Wu Q, Sattar A, Ansari-Gilani K, Labbato D, Fletcher AA, McComsey AD, Eckard AR
Subject & Discipline Open Forum Infect Dis
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-27959
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »